Want to see NAMS full AI Analyst Report?
Technical Sentiment
Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
NewAmsterdam Pharma Company’s (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -1.48, suggesting NewAmsterdam Pharma Company is a Buy.
NewAmsterdam Pharma Company’s (NAMS) 20-Day exponential moving average is 25.61, while NewAmsterdam Pharma Company’s (NAMS) share price is $26.79, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) 50-Day exponential moving average is 27.86, while NewAmsterdam Pharma Company’s (NAMS) share price is $26.79, making it a Sell.
NewAmsterdam Pharma Company (NAMS) Pivot Points
Classic
20.31
21.05
21.46
22.20
22.61
23.35
23.76
Fibonacci
21.05
21.49
21.76
22.20
22.64
22.91
23.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
NewAmsterdam Pharma Company (NAMS) Moving Averages
MA5
23.70Sell
23.43Sell
MA10
24.61Sell
24.40Sell
MA20
25.99Sell
25.61Sell
MA50
28.78Sell
27.86Sell
MA100
30.73Sell
29.73Sell
MA200
32.26Sell
31.50Sell
NewAmsterdam Pharma Company’s (NAMS) 10-Day exponential moving average is 24.40, while NewAmsterdam Pharma Company’s (NAMS) share price is $26.79, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) 100-Day exponential moving average is 29.73, while NewAmsterdam Pharma Company’s (NAMS) share price is $26.79, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) stock price is $26.79 and NewAmsterdam Pharma Company’s (NAMS) 50-day simple moving average is 28.78, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $26.79 and NewAmsterdam Pharma Company’s (NAMS) 100-day simple moving average is 30.73, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $26.79 and NewAmsterdam Pharma Company’s (NAMS) 200-day simple moving average is 32.26, creating a Sell signal.
NewAmsterdam Pharma Company (NAMS) Technical Indicators
RSI (14)
31.83
Neutral
STOCH (9,6)
13.80
Buy
STOCHRSI (14)
10.49
Buy
MACD (12,26)
-1.48
Buy
ADX (14)
42.52
Neutral
Williams %R
-76.84
Buy
CCI (14)
-174.99
Buy
ATR (14)
1.43
-
Ultimate Oscillator
49.06
Neutral
ROC
-18.19
Sell
NewAmsterdam Pharma Company’s (NAMS) Relative Strength Index (RSI) is 31.83, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Trend Strength Indicator (ADX) is 42.52, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Commodity Channel Index (CCI) is -174.99, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) Price Rate of Change (ROC) is -18.19, creating a Sell signal.
FAQ
Is NAMS a Buy, Hold, or Sell?
Based on NAMS’s technical indicators, NAMS is a Sell.
What is NAMS’s RSI (14)?
NAMS’s RSI (14) is 31.83, which suggests NAMS is a Neutral.
What is NAMS’s MACD?
NAMS’s MACD is -1.48, which suggests NAMS is a Buy.
What is NAMS’s 5-day moving average?
NAMS’s 5-day moving average is 23.70, which suggests NAMS is a Sell.
What is NAMS’s 20-day moving average?
NAMS 20-day moving average is 25.99, which suggests NAMS is a Sell.
What is NAMS’s 50-day moving average?
NAMS’s 50-day moving average is 28.78, which suggests NAMS is a Sell.
What is NAMS’s 200-day moving average?
NAMS’s 200-day moving average is 32.26, which suggests NAMS is a Sell.
What is NAMS’s Williams % R (14)?
NAMS’s Williams % R (14) is -76.84, which suggests NAMS is a Buy.
What is NAMS’s CCI (14)?
NAMS’s CCI (14) is -174.99, which suggests NAMS is a Buy.